ClinicalTrials HQ

Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma

Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma

Active, not recruiting · NCT03600441 · Registry updated 2025-04-10
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Abexinostat in Patients With Relapsed or Refractory Follicular LymphomaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmActive, not recruitingPhase 22025-04-10NCT03600441

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Xynomic Pharmaceuticals, Inc.7

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Advocate Medical Group - Park Ridge, Luther Lane - OncologyPark RidgeUnited States2
Arlington Cancer CenterArlingtonUnited States2
Bone Marrow Transplant Hematology Oncology AssociatesPittsburghUnited States1
C.H. Regional Reina SofiaCórdobaSpain6
Central Texas Veterans Health Care System - NAVREFTempleUnited States1
Centre Hospitalier de PerpignanPerpignanFrance1
Clinical Research Alliance IncLake SuccessUnited States1
Hospital del MarBarcelonaSpain1
Hospital Universitario de DonostiaDonostia / San SebastianSpain2
Hospital Universitario Infanta LeonorMadridSpain25
Hospital Universitario Vall d'HebrónBarcelonaSpain4
Manhattan Hematology Oncology CenterNew YorkUnited States1
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Norton Cancer Institute - St. Matthews CampusLouisvilleUnited States1
Vista Oncology Inc. PSOlympiaUnited States1